Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients.

BMC Cardiovasc Disord · 2025 · PMC12750671 · PMID 41466224

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, patients who started on SGLT2i showed a trend toward fewer HF decompensations and a significantly lower rate of non-cardiovascular hospitalizations.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.